Skip to content
Company Intelligence

Top Pharma Capability Profiles

Profile competitors on what they can do.

Live capability profiles of top pharma companies — modality, pipeline, deal pattern, talent and strategic posture.

Decision angle

"How would each top pharma actually move against us — and where are they vulnerable?"

TL;DR

Capability profiles read what a company can do (modality, manufacturing, deal pattern, talent), not what it announces. They predict moves more reliably than press releases.

Static profiles age fast. Live capability profiles, built on capability + pipeline + deal pattern + talent, are how strategy teams actually anticipate competitor moves.

Key insights

What we’re seeing in the data.

01

Capability beats stated strategy

Modality and platform capability predict moves.

02

Deal pattern reveals priorities

Where leadership places conviction.

03

Talent flow is leading indicator

Senior hires precede strategy shifts.

5
Profile dims
Cap/Pipe/Deal/Talent/Geo
Live
Refresh
Continuous
20+
Companies/TA
Tracked
36mo
Horizon
Forward
Decision framework

How to think about it.

  1. 01

    Define capability dimensions

    Modality / mfg / platform / geo.

  2. 02

    Map pipeline portfolio

    TA × phase × modality.

  3. 03

    Track deal pattern

    M&A / licensing history.

  4. 04

    Monitor talent flow

    Senior hires & reorgs.

Considerations

What separates a good answer from a defensible one.

Public vs private signal

Calls signal strategy; deals show capability.

Integration capacity

Recent M&A absorbs bandwidth.

CEO transitions

Materially shift strategy.

Sources & tools

Where the signal comes from.

Cortellis Deals Citeline Public filings LinkedIn talent flow Patent databases
FAQ

Common questions.

Refresh cadence?

Live for events; quarterly synthesis.

Profile or dashboard?

Dashboard with embedded narrative — beats slide decks.

Want this answered on your data?

We build decision systems on top of analyses like this — so the next question takes minutes, not weeks.

Talk to a strategist